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Evaluation of Chronic Granulomatous Disease by a Chemiluminescence Assay of Microiter Quantities of Whole Blood
Lawrence R. DeChatelet and Pamela S. Shirley
In our modification of a chemiluminescence assay to detect chronic granulomatous disease of childhood, whole blood is used and dark-adaptation is not required. This improvement was made possible by the use of luminol as an amplification device and of phorbol myristateacetate as a stimulant. Using this simplified assay, we can assess neutrophil function wIth 25-100 L of whole blood, permilling simple evaluation even in very young pediatric patients.
AddItional Keyphrases:
pediatric chemlst,y #{149} screening newborns Phagocytosis by polymorphonuclear leukocytes (PMN) elicits a burst of oxidative metabolism that is intimately associated with the bactericidal activity of the cell (1).1 PMN from patients with chronic granulomatous disease (CGD), which cannot kill most bacteria and fungi, do not undergo this "respiratory burst" (2) . Thus, measurement of the respiratory burst in one fashion or another is generally considered a requisite for a definitive diagnosis of CGD. One of the hallmarks of the respiratory burst is the generation of a burst of chemiluminescence, which can be quantitated in a liquid scintillation spectrometer (3) . Although this is one of the most sensitive measurements of neutrophil oxidative activity, its use as a diagnostic tool has been hampered by technical problems. It has been necessary to first isolate the leukocytes from whole blood; this is a time-consuming process and sufficient quantities of blood are not always easily obtainable from pediatric patients. Further, all materials are dark-adapted and the procedure must be performed in a darkened room under red light, to minimize background values. Again, this is frequently impracticable in an active laboratory.
We have devised a modified procedure, which can be performed on microliter quantities of whole blood without the necessity for dark-adaptation or use of red light. This provides a very sensitive and economical procedure for diagnosis of patients with CGD. 
Materials and Methods
The assay revolves about the use of luminol (Sigma Chemical Co., St. Louis, MO 63178) as an amplifier (4) and sufficient PBS to yield a final volume of 2.0 mL. To determine the measurement of activated cellular chemiluminescence, the vials also contained 0.20 mL of PMA (10 tg/mL).
In one experiment, the PMA was replaced by 2.0mg of zymosan (Sigma Chemical Co.) to initiate phagocytosis. Reaction was initiated by adding whole blood (25-100 giL) or isolated human neutrophils. All operations were performed in a lighted room. Blood (heparinized) was added to the vials at 1-mm intervals and the chemiluminescence was measured for 1.0 mm each. With this instrument, the optimal number of samples was eight, which permits duplicate determinations of a patient and control sample under resting and activated conditions. When the last sample was placed in the counter, the cover was closed and the operation mode was set to repeat cycle. With eight samples, the recycling time was 10 (SD 0.10) mm so that each sample was counted automatically every 10 mm. The initial (zero time) values were spurious, owing to luminescence of the vials, and were disregarded. However, the lO-min time points were reproducible, and because the resting values did not vary substantially during 2 h, it was a simple matter to extrapolate to the zero-time value. (shown in Figure 2 ) with normal human blood, there was no significant difference in response with volumes of blood ranging from 25 to 100 L. This was in contrast to the situation with isolated neutrophils, where the magnitude of the peak response was directly proportional to the number of cells in the assay (Figure 3 ). For this experiment, cells were isolated from heparinized venous blood by standard methods
Results

(5).
We also evaluated the use of a phagocytic stimulus (zymosan) in the present assay, as shown in Figure 4 . In this particular experiment, 0.05 mL of whole blood was activated by either PMA (1 mg/L) or zymosan (1 g/L). The peak value of chemiluminescence induced by the zymosan was approximately 28000 cpm (with a background of 5000 cpm). In con- no significant change in resting cell chemiluminescence during 90 mm. However, in the presence of PMA, the chemiluminescence gradually increased from a background level of 7500 cpm to a maximum of 57 000 cpm within 60 mm. In contrast, blood from a patient with CGD showed no significant differ- Eachreactionmixttse contained 1 tmoI of luminol per liter and 50 tL ofwhole blood trast, the PMA induced a peak response of 120 000 cpm. Thus, for use as a screening assay, stimulation by PMA appears to be much preferable in terms of increased sensitivity.
DiscussIon
Diagnosis of COD has usually involved measurement, in isolated neutrophils, of various aspects of the respiratory burst made. This involves both a considerable quantity of blood and substantial technical time. Currently, the only relatively simple test involves the histochemical reduction of NBT, a procedure that can be performed on small samples of whole blood (6) . However, it is semiquantitative at best and is relatively insensitive (7) . Further, the NBT test is tedious in that a number of cells (e.g., 100) must be examined microscopically and scored for the presence or absence of reduced dye.
The present procedure has significant advantages for routine screening for CGD. It is highly sensitive and extremely simple to perform, the total experimental time being approximately 15 mm. Once the samples are placed in the scintillation counter, the rest of the procedure is completely automated. Little whole blood is required because the luminol enhances the chemiluminescence.
This makes the test ideal for use in evaluation of even newborn infants. Further, the ability to perform the test under normal laboratory conditions removes most of the usual objections because a darkened room and the use of red light are not required.
When the test is performed on whole blood, the response is relatively independent of the number of cells used ( Figure  2 ), so that variations in numbers of circulating leukocytes are not crucial. This independence of the luminescence response with whole blood is probably due to the presence of hemoglobin, which causes some quenching of the fluorescence. Both magnitude of the response and the shape of the curve vary substantially from day to day (compare Figures 1 and 2 ), but this in no way detracts from the usefulness of this test in screening for CGD, because an all-or-nothing response is obtained ( Figure 1) .
A very recent abstract has described a similar test in which a phagocytic stimulus was used rather than PMA in the presence of luminol.2 This likewise permitted determination of respiratory-burst activity on microliter quantities of whole blood, but no mention was made of using the assay to detect CGD. It appears as though this technique will be the most sensitive and rapid for detetting disorders of the oxidative metabolism of phagocytes.
